Press Releases

Sills Cummis & Gross Launches a Regulated Substances Practice

April 14, 2015

Sills Cummis & Gross has launched a Venture Capital/Regulated Substances Practice, building on the Firm’s strong transactional practice.  Jeffrey L. Wasserman, a Member of the Firm’s Corporate Department, who focuses on venture capital and private equity deals, is leading the new group, assisted by Associate John Weldon. 

Wasserman stated: “We are already representing clients investing in the legal cannabis-related marketplace and believe now is a great time to launch this practice, given the explosion of various states around the U.S. authorizing the use of legalized medical and recreational cannabis.  While New Jersey is discussing the issue, current corporate and institutional clients are looking for legal counsel to prepare them for current and future investment opportunities in New Jersey, New York and the rest of the East Coast.”  

The newly formed Practice is designed to assist clients in managing the risks and opportunities in the rapidly evolving legal medical and recreational cannabis market.      

                                                                 ###

PLEASE BE MINDFUL THAT POSSESSING, USING, DISTRIBUTING AND/OR SELLING MARIJUANA IS A FEDERAL CRIME, AND NO LEGAL ADVICE WE GIVE IS INTENDED TO PROVIDE ANY GUIDANCE OR ASSISTANCE IN VIOLATING FEDERAL LAW NOR WILL IT PROVIDE ANY GUIDANCE OR ASSISTANCE  IN COMPLYING WITH FEDERAL LAW.   PLEASE ALSO NOTE THAT WE ARE NOT ADVISING YOU REGARDING THE FEDERAL, STATE OR LOCAL TAX CONSEQUENCES OF ENGAGING IN ANY BUSINESS IN THIS INDUSTRY.